Picture of Hanyuan Biotech International logo

TNPH Hanyuan Biotech International Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Hanyuan Biotech International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2005
December 31st
2006
December 31st
2007
December 31st
Period Length:12 M12 M12 M
Source:10KSB10KSB10KSB
Standards:
USG
USG
USG
Status:FinalFinalFinal
Net Income/Starting Line1.061.523.14
Depreciation
Non-Cash Items0.1010.0040.137
Other Non-Cash Items
Changes in Working Capital0.262-0.537-1.22
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Cash from Operating Activities1.741.462.56
Capital Expenditures-1.82-0.051-0.007
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items00.0130
Sale of Fixed Assets
Cash from Investing Activities-1.82-0.038-0.007
Net Issuance / Retirement of Stock
Cash from Financing Activities1.860
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.911.633.04